Sunshine Biopharma Inc. (SBFM) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $24.05M | -0.6% |
| 2024 | $24.20M | +53.6% |
| 2023 | $15.75M | +494.7% |
| 2022 | $2.65M | +2148.2% |
| 2021 | $117.8K | +355.9% |
| 2020 | $25.8K | +133.9% |
| 2019 | $11.1K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $24.05M | -0.6% |
| 2024 | $24.20M | +53.6% |
| 2023 | $15.75M | +494.7% |
| 2022 | $2.65M | +2148.2% |
| 2021 | $117.8K | +355.9% |
| 2020 | $25.8K | +133.9% |
| 2019 | $11.1K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |